Eleonor Health

LEO-HB, operated under parent company Eleonor (founded in 2007), is a specialty ingredient technology company focused on improving the bioavailability and bio-accessibility of poorly soluble natural ingredients for the dietary supplement, health and wellness, and animal nutrition markets. The company's core proprietary platform, LEO-HB® Technology, is a solvent-free and surfactant-free solid dispersion mechanical process that transforms poorly soluble, crystalline active ingredients into an amorphous state. This transformation enables cold water dispersibility and solubility while increasing bioavailability by 2x to 13x compared to conventional forms. The process is clean-label, single-step, and uses only non-GMO, food-grade ingredients of natural origin — with no PEG, no polysorbates, no synthetic excipients, and no solvents, ensuring no negative impact on the digestive tract. LEO-HB® technology specifically addresses both inter-individual and intra-individual variability in active ingredient absorption, resulting in more consistent and efficacious outcomes for end consumers. The company offers three primary service models for B2B customers. First, a proprietary ingredients line featuring a portfolio of high-performance cold water dispersible and soluble bioactive powders ready for formulation into finished products. Second, a custom ingredients development service, where the team designs tailored single or combination bioactive ingredients to meet specific brand requirements. Third, a turn-key ingredient development program that includes full R&D support, international patent protection, pre-clinical and clinical studies, and exclusivity options for brand partners seeking a clinically validated, IP-protected competitive advantage. LEO-HB® also partners with ingredient suppliers whose existing actives fall under BCS Class II or Class IV biopharmaceutical classification — categories known for poor solubility and limited bioavailability — to enhance those ingredients' functionality and market performance. The company's technology allows brands to reduce daily intake requirements of active ingredients, lowering raw material usage, improving consumer compliance, and delivering cost savings. The leadership team combines over two decades of experience in bioavailability improvement, intellectual property, contract research, food science, biotechnology, and ingredients sales and marketing. LEO-HB® holds international patents on its technology and ingredient innovations, positioning it as a differentiated partner for nutraceutical brands, functional food manufacturers, and ingredient suppliers seeking next-generation performance ingredients.